GemPharmatech Co., Ltd. (SHA:688046)
11.60
-0.13 (-1.11%)
At close: May 23, 2025, 2:57 PM CST
GemPharmatech Company Description
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project.
It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services.
The company was founded in 2017 and is headquartered in Nanjing, China.
GemPharmatech Co., Ltd.
Country | China |
Founded | 2017 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 1,578 |
CEO | Jing Zhao |
Contact Details
Address: No. 12 Xuefu Road Nanjing, 210032 China | |
Website | gempharmatech.com |
Stock Details
Ticker Symbol | 688046 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100005964 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Jing Zhao Ph.D. | GM and Director |
Chongbo Xu CPA, M.B.A. | Chief Financial Officer |
Zhongyu Li | Deputy GM and Director |
Tao Wang | Deputy GM and Director |
Yiou Wang | Board Secretary |
Dr. Hong-Yu Wang Ph.D. | Chief Technology Officer |
Hongyan Sun | Deputy Director of Functional Pharmacodynamics Center |